Intrinsic Value of S&P & Nasdaq Contact Us

1CM Inc. MILFF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
54/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

1CM Inc. (MILFF) trades at a trailing P/E of 31.6. Trailing earnings yield is 3.17%.

Criteria proven by this page:

  • VALUE (60/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Trailing Earnings Yield 3.17% — roughly competitive with bond yields (~4.3%), moderate risk-reward.

Overall SharesGrow Score: 52/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
54/100
SG Score
View full scorecard →
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
~
PAST
50/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
15/100
→ Income
GROWTH
100/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — MILFF

Valuation Multiples
P/E (TTM)31.6
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.21
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.62
FCF / Share$0.00
Yields & Fair Value
Earnings Yield3.17%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.00 $0.00 $-52K -
2017 $0.00 $0.00 $-58.98K -
2018 $-0.16 $82.27K $-6.38M -7752.9%
2019 $-0.34 $118.5K $-28.53M -24074.5%
2020 $-0.03 $72.73K $-2.82M -3874.5%
2021 $-0.05 $341.81K $-4.56M -1333.5%
2022 $-0.05 $842.49K $-4.73M -561.1%
2023 $-0.01 $35.34M $-914K -2.6%
2024 $0.01 $57.22M $615.91K 1.1%
2025 $0.00 $73.32M $484.52K 0.7%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message